Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenes
The DOI matches its Crossref record.
Abstract
We have used severe‐combined immunodeficient (SCID) mice to examine the immunoregulatory effects of interleukin (IL)‐10 on innate resistance to infection with Listeria monocytogenes. Addition of heat killed Listeria to spleen cells from naive SCID mice resulted in secretion of interferon (IFN)‐γ from natural killer cells in vitro. This response was enhanced up to 15‐fold in the presence of exogenous IL‐2, but was completely ablated by addition of IL‐10 with an IC 50 of < 0.5 U/ml. Infection of SCID mice with viable Listeria in vivo resulted in a prolonged course of infection eventually causing death by 12–14 days, whereas daily administration of IL‐10 increased bacterial replication in the liver and spleen by up to 1000‐fold resulting in death by day 4 post‐infection. The immunosuppressive actions of IL‐10 in vivo were also observed in immunocompetent BALB/c mice, where doses as low as 100 U/day converted a sublethal infection to 100% mortality. To study the events controlling expression of endogenous IL‐10, peritoneal macrophage monolayers were challenged with Listeria after pre‐incubation with a panel of recombinant cytokines. IFN‐γ primed macrophages for enhanced tumor necrosis factor (TNF) secretion, but inhibited IL‐10 production, whereas granulocyte/macrophage colony‐stimulating factor (CSF), macrophage CSF and also IL‐4 enhanced macrophage IL‐10 responses after ingestion of Listeria in vitro. Finally, monoclonal antibody neutralization of IFN‐γ during infection of SCID mice with Listeria inhibited TNF‐α mRNA, but augmented expression of IL‐10 mRNA in infected tissues. These results demonstrate that exogenous IL‐10 is a potent immunosuppressive cytokine in the context of infection with an intracellular bacterium and that expression of endogenous IL‐10 versus TNF is differentially regulated by the cytokine environment of the macrophage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
The two faces of interleukin 10 in human infectious diseases
Mege, J.-L., Meghari, S., Honstettre, A., Capo, C., & Raoult, D. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70577-1 · Cited by 257
Unanue, E. R. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80156-2 · Cited by 212
The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion
Ağaç, D., Estrada, L. D., Maples, R., Hooper, L. V., & Farrar, J. D. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.004 · Cited by 200
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138
Metadata
- Authors
- Kelly, J. P., & Bancroft, G. J.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-02
- Volume
- 26
- Issue
- 2
- Pages
- 356-364
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2101126366
- Cited by
- 63
- References
- 0
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenes. https://app.cochat.ai/papers/10.1002/eji.1830260214
- The paper
- Kelly, J. P., & Bancroft, G. J. (1996). Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenes. European Journal of Immunology. https://doi.org/10.1002/eji.1830260214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.